Farmalia SRL
Farmalia reported total assets of 397,775 € at the end of the 2025 financial year (annual accounts filed with the NBB on 15 Jun 2026).
The score of Farmalia shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets -26 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Farmalia's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 8,777 € | ||||
| Equity | −15,097 € | ||||
| Cash | 17,805 € | ||||
| EBITDA | 43,691 € | ||||
| Total assets | 397,775 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 15 Jun 2026
- Year ended 31 Dec 2024filed on 30 Jun 2025
- Year ended 31 Dec 2023filed on 28 Jun 2024
- Year ended 31 Dec 2022filed on 19 Jul 2023
- Year ended 31 Dec 2021filed on 04 Jul 2022
Farmalia's financial analysis
- Solvency-3.8%sector median: 37.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Farmalia
Farmalia's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0630.931.055
- VAT number
- BE0630931055
- Peppol
- Registered · 0208:0630931055 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 29 May 2015
- Registered office
- 1040 Etterbeek
- Latest accounts
- 2025 · filed on 15 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Farmalia (SRL) has been based in Etterbeek since 2015, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 8,777 € and equity of −15,097 €; its revenue is not published. Its solvency stands at -3.8%, below the median of its sector (37.8%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Farmalia
Companies in the same business, of comparable size and area, outside its group.
- Les Pharmacies Réunies Retail sale of pharmaceutical products Frameries · balance sheet 389,988 €
- Apotheek Janssen Retail sale of pharmaceutical products Knokke-Heist · balance sheet 398,271 €
- Pharmacie Dosogne Retail sale of pharmaceutical products Gembloux · balance sheet 398,660 €
- ulti med Products (Belgium) Retail sale of pharmaceutical products Roeselare · balance sheet 399,335 €
- Minphar Retail sale of pharmaceutical products Molenbeek-Saint-Jean · balance sheet 396,164 €
- Mega Pharma Retail sale of pharmaceutical products Molenbeek-Saint-Jean · balance sheet 399,682 €
- Offipharma Retail sale of pharmaceutical products Froidchapelle · balance sheet 399,757 €
- Pharmaplus Rocourt Retail sale of pharmaceutical products Liège · balance sheet 400,037 €
Frequently asked questions about Farmalia
What is the revenue of Farmalia?
Farmalia files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Farmalia?
In Belgium, the VAT number is the company number prefixed with BE: BE0630931055 for Farmalia, if the company is VAT-registered. Its company number (CBE) is 0630.931.055.
Where is the registered office of Farmalia?
According to the CBE register, the registered office of Farmalia is in 1040 Etterbeek.
What is the equity of Farmalia?
At the close of the 2025 financial year, the equity of Farmalia amounts to -15,097 €, a solvency of -3.8% of total assets.
Who manages Farmalia?
The register lists 1 active mandates at Farmalia. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Farmalia
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →